ArticleScientific reports2025
A recurrent multimodal sparse transformer framework for gastrointestinal disease classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advancements in Machine Learning-Assisted Flexible Electronics: Technologies, Applications, and Future Prospects.Biosensors · 2026Pooled it
- LightGastroFormer: a lightweight multi-resolution transformer for gastrointestinal disease classification.Scientific reports · 2026Article
- A hybrid ViT-L/32-MaxViT-L architecture with adaptive gated fusion for multiclass gastrointestinal disease detection and multi-methodFrontiers in endocrinology · 2026Article
- Artificial intelligence-driven gastrointestinal functional assessment: multimodal imaging, digital biomarkers, and real-time monitoring.Frontiers in physiology · 2026Review
- Multi-stage convo-enhanced retinex canny DeepLabv3+ FusionNet for enhanced detection and classification of bleeding regions in GI tract.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and early diagnosis of gastrointestinal (GI) tract diseases is essential for effective treatment planning and improved patient outcomes. However, existing diagnostic frameworks often face limitations due to modality imbalance, feature redundancy, and cross-modal inconsistencies, particularly when dealing with heterogeneous data such as medical text and endoscopic images. To bridge these gaps, this study proposes a novel recurrent multimodal principal gradient K-proximal sparse transformer (RMP-GKPS-transformer) framework for comprehensive GI disease classification. The approach integrates clinical text and WCE images using a robust multi-modal fusion strategy that incorporates Bio-RoBERTa for textual feature extraction, a graph vision spatial channel attention transformer network for image feature learning, and cross-attention mechanisms for modality alignment. Further, the model employs principal component analysis (PCA) for dimensionality reduction and gradient boosting machines (GBMs) for semantic conflict resolution. Classification is performed using an ensemble of random forest KNN, proximal policy optimization (PPO), and a sparse radial basis function (RBF) kernel to ensure accuracy and interpretability. Experimental evaluation on publicly available datasets achieved 99.82% accuracy, a Dice coefficient of 98.7%, and significantly lower execution time compared to state-of-the-art methods. The results confirm the framework's effectiveness in aligning and leveraging multi-modal data for precise classification of six GI diseases, offering a scalable and interpretable solution for enhanced clinical decision-making in gastroenterology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.